Camba-Pharma SRL
The score of Camba-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +172 % Total assets -5 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Camba-Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 47,651 € | ||||
| Equity | 137,100 € | ||||
| Cash | 6,440 € | ||||
| EBITDA | 69,254 € | ||||
| Total assets | 437,825 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Apr 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
- Year ended 31 Dec 2023filed on 19 Jul 2024
- Year ended 31 Dec 2022filed on 02 Jul 2023
- Year ended 31 Dec 2021filed on 05 Jul 2022
Camba-Pharma's financial analysis
- Solvency31.3%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Camba-Pharma
Camba-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0717.740.414
- VAT number
- BE0717740414
- Peppol
- Registered · 0208:0717740414 · as of 05 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Jan 2019
- Registered office
- 9031 Ghent
- Latest accounts
- 2025 · filed on 08 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Camba-Pharma (SRL) has been based in Ghent since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 47,651 € and equity of 137,100 €; its revenue is not published. Its solvency stands at 31.3%, below the median of its sector (44.0%).
Companies similar to Camba-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Holding Pirotte Laura Activities of holding companies Houyet · balance sheet 464,856 €
- Nomota Activities of holding companies Berlaar · balance sheet 381,263 €
- Satilmis Retail sale of pharmaceutical products Saint-Gilles · balance sheet 304,962 €
- Apotheek DE Zuidflank Retail sale of pharmaceutical products Assenede · balance sheet 722,912 €
- B&B Pharma Retail sale of pharmaceutical products Beersel · balance sheet 811,436 €
- Bloos Retail sale of pharmaceutical products Anzegem · balance sheet 824,528 €
- Verzele Pharma Zwalm Retail sale of pharmaceutical products Oudenaarde · balance sheet 431,191 €
- Donk DCL Farma Retail sale of pharmaceutical products Herk-de-Stad · balance sheet 897,538 €
Frequently asked questions about Camba-Pharma
What is the revenue of Camba-Pharma?
Camba-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Camba-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0717740414 for Camba-Pharma, if the company is VAT-registered. Its company number (CBE) is 0717.740.414.
Where is the registered office of Camba-Pharma?
According to the CBE register, the registered office of Camba-Pharma is in 9031 Ghent.
What is the equity of Camba-Pharma?
At the close of the 2025 financial year, the equity of Camba-Pharma amounts to 137,100 €, a solvency of 31.3% of total assets.
Who manages Camba-Pharma?
The register lists 1 active mandates at Camba-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Camba-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →